CH671229A5 - - Google Patents

Download PDF

Info

Publication number
CH671229A5
CH671229A5 CH4717/86A CH471786A CH671229A5 CH 671229 A5 CH671229 A5 CH 671229A5 CH 4717/86 A CH4717/86 A CH 4717/86A CH 471786 A CH471786 A CH 471786A CH 671229 A5 CH671229 A5 CH 671229A5
Authority
CH
Switzerland
Prior art keywords
thr
leu
ser
gly
lys
Prior art date
Application number
CH4717/86A
Other languages
German (de)
English (en)
Inventor
Francois Dr Cardinaux
Janos Dr Pless
Robert Helmut Dr Buck
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of CH671229A5 publication Critical patent/CH671229A5/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/585—Calcitonins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/107—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Endocrinology (AREA)
  • Analytical Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CH4717/86A 1985-12-04 1986-11-25 CH671229A5 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE3542859 1985-12-04
DE3614784 1986-05-02

Publications (1)

Publication Number Publication Date
CH671229A5 true CH671229A5 (pl) 1989-08-15

Family

ID=25838500

Family Applications (1)

Application Number Title Priority Date Filing Date
CH4717/86A CH671229A5 (pl) 1985-12-04 1986-11-25

Country Status (20)

Country Link
US (1) US4758550A (pl)
JP (1) JPH085916B2 (pl)
KR (1) KR880006263A (pl)
AU (1) AU600242B2 (pl)
BE (1) BE905849A (pl)
CH (1) CH671229A5 (pl)
DK (1) DK580186A (pl)
ES (1) ES2012510A6 (pl)
FI (1) FI864939A (pl)
FR (1) FR2590902B1 (pl)
GB (1) GB2184729B (pl)
GR (1) GR862836B (pl)
HU (1) HUT44794A (pl)
IL (1) IL80846A0 (pl)
IT (1) IT1214754B (pl)
LU (1) LU86697A1 (pl)
NL (1) NL8602950A (pl)
NZ (1) NZ218473A (pl)
PT (1) PT83835B (pl)
SE (1) SE8605189L (pl)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3876022T2 (de) * 1987-07-08 1993-04-22 Mitsubishi Petrochemical Co Calcitonin-derivate und deren salze.
AU609911B2 (en) * 1987-12-16 1991-05-09 Rorer International (Overseas) Inc. 8-glycine,16-x, des-19-leucine-calcitonin
GB2218102B (en) * 1988-04-08 1992-09-16 Sandoz Ltd Calcitonin peptide derivatives
US5153308A (en) * 1988-06-16 1992-10-06 Teijin Limited S-sulfonated calcitonin derivatives
US5026825A (en) * 1988-09-08 1991-06-25 Rhone-Poulenc Rorer Pharmaceuticals Inc. Intranasal calcitonin formulations
DE68912090T2 (de) * 1988-11-24 1994-06-16 Mitsubishi Petrochemical Co Calcitonin-Derivate und deren Salze.
AU5194990A (en) * 1989-02-23 1990-09-26 Rorer International (Holdings), Inc. Therapeutic aerosol formulations
US5204326A (en) * 1989-03-16 1993-04-20 Otsuka Pharmaceutical Co., Ltd. Polypeptide derivatives and calcium metabolism improving agent
EP0423326B1 (en) * 1989-04-21 1998-08-26 TSUMURA & CO. Novel physiologically active peptide and calcium metabolism-regulating agent comprising said peptide as effective ingredient
US5364840A (en) * 1989-12-05 1994-11-15 Vical, Inc. Synthetic calcitonin peptides
US5175146A (en) * 1989-12-05 1992-12-29 Vical, Inc. Synthetic calcitonin peptides
CS89491A3 (en) * 1990-04-09 1992-01-15 Chugai Pharmaceutical Co Ltd Hybrid calcitonin
ES2051647B1 (es) * 1992-12-10 1995-01-16 Lipotec Sa Procedimiento para la preparacion de calcitonina de salmon.
US5710244A (en) * 1992-12-31 1998-01-20 Labroo; Virender M. Derivatized calcitonins
AU673237B2 (en) * 1992-12-31 1996-10-31 University Of Washington Derivatized calcitonins
DE726075T1 (de) * 1995-02-08 1996-12-12 Therapicon Srl Nicht-inorganische pharmazeutische salzige Lösungen zur endonasale Verabreichung
US5955434A (en) * 1995-02-09 1999-09-21 Brigham & Women's Hospital Gel-forming polypeptide derivatives
KR960031478A (ko) * 1995-02-14 1996-09-17 성재갑 유비퀴틴 융합 인간 칼시토닌의 정제방법
US6034064A (en) * 1995-04-07 2000-03-07 Hoechst Pharmaceuticals & Chemicals K.K. Peptides and therapeutic agent for autoimmune diseases containing the same
US5721207A (en) * 1995-04-18 1998-02-24 Innapharma, Inc. Method for treatment of pain
US6936584B1 (en) 1998-02-13 2005-08-30 Amylin Pharmaceuticals, Inc. Mixed amylin activity compounds
ES2356595T3 (es) 1998-02-13 2011-04-11 Amylin Pharmaceuticals, Inc. Nuevos compuestos de actividad mixta de la amilina.
CA2643826A1 (en) * 2006-02-27 2008-06-12 Paul A. Wender Compositions and methods for transport of molecules with enhanced release properties across biological barriers
CA2855122A1 (en) * 2011-12-09 2013-06-13 The Regents Of The University Of California Modified mini-hepcidin peptides and methods of using thereof
WO2013162729A1 (en) 2012-04-24 2013-10-31 The Board Of Trustees Of The Leland Stanford Junior University Method for delivery of small molecules and proteins across the cell wall of algae using molecular transporters

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3926938A (en) * 1974-08-12 1975-12-16 Armour Pharma Synthesis of salmon calcitonin
JPS51128993A (en) * 1975-05-01 1976-11-10 Tanpakushitsu Kenkyu Shiyoureikai Process for preparing new polypeptides
GB1592969A (en) * 1976-09-13 1981-07-15 Armour Pharma Hentriacontapeptides and preparation thereof
JPS60500054A (ja) * 1983-02-15 1985-01-17 ア−マ−・フア−マシユ−テイカル・カンパニ− デス−アスパラギン−３−カルシトニン
US4663309A (en) * 1983-06-29 1987-05-05 University Patents, Inc. Novel peptide hormones with calcitonin-like activity
GB8327346D0 (en) * 1983-10-12 1983-11-16 Morris H R Peptide
US4497732A (en) * 1983-10-21 1985-02-05 Armour Pharmaceutical Company 1A-Endo-glycine-calcitonin
US4537716A (en) * 1983-12-05 1985-08-27 Armour Pharmaceutical Co. Des-serine2 or des-glycine2 -leucine22 calcitonin
US4622386A (en) * 1985-03-28 1986-11-11 Armour Pharmaceutical Company [1,7-di-alanine]calcitonin
US4658014A (en) * 1985-12-20 1987-04-14 Kempe Tomas G Synthetic peptides with calcitonin-like activity
AU7468687A (en) * 1987-06-23 1989-01-05 Armour Pharmaceutical Company (n-acyl, 1,7-di-alanine) calcitonin

Also Published As

Publication number Publication date
IL80846A0 (en) 1987-03-31
GB2184729A (en) 1987-07-01
AU600242B2 (en) 1990-08-09
US4758550A (en) 1988-07-19
JPS62132898A (ja) 1987-06-16
KR880006263A (ko) 1988-07-22
PT83835B (pt) 1989-06-30
LU86697A1 (fr) 1987-07-24
ES2012510A6 (es) 1990-04-01
SE8605189L (sv) 1987-06-05
SE8605189D0 (sv) 1986-12-03
DK580186A (da) 1987-06-05
FR2590902A1 (fr) 1987-06-05
HUT44794A (en) 1988-04-28
FI864939A (fi) 1987-06-05
NL8602950A (nl) 1987-07-01
IT1214754B (it) 1990-01-18
IT8648701A0 (it) 1986-12-04
AU6606186A (en) 1987-06-11
GR862836B (en) 1987-04-02
FI864939A0 (fi) 1986-12-03
DK580186D0 (da) 1986-12-02
FR2590902B1 (fr) 1994-12-23
GB8628739D0 (en) 1987-01-07
GB2184729B (en) 1990-07-25
BE905849A (fr) 1987-06-03
JPH085916B2 (ja) 1996-01-24
PT83835A (en) 1986-12-01
NZ218473A (en) 1990-03-27

Similar Documents

Publication Publication Date Title
CH671229A5 (pl)
DE2616399C2 (de) Desamino-1,7-dicarbacalcitonine und Verfahren zu ihrer Herstellung
DE3428942C2 (de) (h-pth)-peptidderivate
CH682152A5 (pl)
DE3144818A1 (de) C-terminales fragment von menschlichem choriongonadotropin
DE3207311A1 (de) Neue n-acylpolypeptide und ihre herstellung
US4562175A (en) Synthetic peptides
JPH04501257A (ja) 心房性ナトリウム利尿ペプチドクリアランス阻害剤
WO1992006998A1 (de) Cyclopeptide, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
EP0021169B1 (de) Verfahren zur selektiven Bildung von Disulfidbrücken in Polypeptiden und die dabei erhaltenen Produkte als Wirkstoffe enthaltende Arzneimittel
DE3614833A1 (de) Peptide mit vasorelaxierender, natriuretischer und diuretischer wirkung, verfahren zu ihrer herstellung, diese enthaltende mittel und ihre verwendung
DE3780000T2 (de) Peptidverbindungen.
DE3783579T2 (de) Derivate des alpha-anp und ihre herstellung.
EP0249169A2 (de) Peptide mit Einfluss auf die Diurese und Natriurese, Verfahren zu ihrer Herstellung, diese enthaltende Mittel und ihre Verwendung
CH626328A5 (en) Process for the preparation of somatostatin analogues
DE3811193A1 (de) Neue peptide, verfahren zu ihrer herstellung und diese peptide enthaltende pharmazeutische zusammensetzungen
DE2659758A1 (de) Carba-derivate von somatostatin, verfahren zu ihrer herstellung und arzneimittel
DE3881467T2 (de) Vasokonstriktor-Peptid.
DE3586940T2 (de) Polypeptid und dessen Verfahren zur Herstellung.
EP0051205A1 (de) Neues Tridekapeptid, Verfahren zu seiner Herstellung und Verwendung
DE2751026A1 (de) Verfahren zur herstellung von peptiden, die tyrosinsulfat enthalten
DE3328952A1 (de) Neue polypeptide, verfahren zu ihrer herstellung, pharmazeutische praeparate welche sie enthalten, sowie ihre verwendung
DE2461673A1 (de) Verbindung mit serumcalciumreduzierender aktivitaet
DE2830489A1 (de) Psychopharmakologisch wirksame peptide
DE2901478A1 (de) Beta tief h -endorphin-analoge und deren herstellung

Legal Events

Date Code Title Description
PFA Name/firm changed

Owner name: SANDOZ AG TRANSFER- NOVARTIS AG

PL Patent ceased